相关临床试验
148
13 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
4
2.7%
已完成
103
69.6%
Enrolling By Invitation
1
0.7%
尚未招募
8
5.4%
招募中
14
9.5%
Unknown
16
10.8%
撤回
2
1.4%
暂无批准数据
- A large international study of over 30,000 participants found fewer than 20% of people reach flavanol intake levels linked to reduced cardiovascular mortality, even among those eating five daily servings of fruits and vegetables. - The COSMOS clinical trial previously demonstrated that consuming 500 mg of flavanols per day significantly lowered the risk of death from heart disease, yet most individuals fall well short of this target. - Researchers identified plums, cranberries, blackberries, green tea, and broad beans as the richest dietary flavanol sources, emphasizing that specific food choices matter more than total fruit and vegetable quantity. - Experts suggest current dietary guidelines like the NHS Eatwell Guide may need refinement to help people obtain beneficial bioactive compounds beyond vitamins and minerals.
- Researchers from the University of Reading and Technical University of Denmark demonstrated that mRNA technology can protect muscle tissue from snake venom-induced damage for the first time. - The treatment uses mRNA wrapped in lipid nanoparticles to teach cells to produce protective antibodies, reducing muscle damage from Bothrops asper venom within 12-24 hours. - Laboratory tests showed the approach reduced key muscle damage markers like creatine kinase and lactate dehydrogenase while preserving healthy muscle structure. - The technology could address a critical gap in snakebite treatment, as current antivenoms struggle to reach damaged muscle tissue around bite sites.
- The second annual London Biotechnology Show (#LBS25) builds on the success of its inaugural edition, which attracted over 3,000 attendees from 1,500 companies and featured 70+ sponsors and exhibitors. - This year's expanded event features a 4,000 square meter floor plan showcasing cutting-edge products and services from leading companies including Discovery Park, Merck, Microsoft, and AstraZeneca. - The show introduces a Hosted Buyer Programme offering pre-arranged one-to-one meetings to facilitate strategic partnerships and business growth opportunities. - An enhanced conference program will feature speakers from major organizations including Novo Nordisk, Pfizer, Bayer Pharmaceuticals, and the Medicines and Healthcare products Regulatory Agency discussing gene editing, regenerative medicine, and digital health innovations.
